Clinical Trial Update: Efficacy and Safety of SPC1001 in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 2 study assessing the efficacy and safety of SPC1001 in adults with essential hypertension, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• SPC1001

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Hypertension, Essential, Cardiovascular Diseases | Phase 2 | Status: RECRUITING